Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03944772
Title Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) (ORCHARD)
Acronym ORCHARD
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ESP

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site Los Angeles California 90048 United States Details
Research Site Sacramento California 95817 United States Details
Research Site Santa Monica California 90404 United States Details
Research Site New Haven Connecticut 06510 United States Details
Research Site Chicago Illinois 60612 United States Details
Research Site Baltimore Maryland 21224 United States Details
Research Site Boston Massachusetts 02114 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Grand Rapids Michigan 49503 United States Details
Research Site New York New York 10017 United States Details
Research Site New York New York 10032 United States Details
Research Site Portland Oregon 97239 United States Details
Research Site Pittsburgh Pennsylvania 15232 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Seattle Washington 98109 United States Details
Research Site Odense C 5000 Denmark Details
Research Site Catania 95123 Italy Details
Research Site Napoli 80131 Italy Details
Research Site Orbassano 10043 Italy Details
Research Site Padova 35128 Italy Details
Research Site Varese 21100 Italy Details
Research Site Chuo-ku 104-0045 Japan Details
Research Site Fukuoka-shi 812-8582 Japan Details
Research Site Koto-ku 135-8550 Japan Details
Research Site Nagoya-shi 464-8681 Japan Details
Research Site Osaka-shi 541-8567 Japan Details
Research Site Wakayama-shi 641-8510 Japan Details
Research Site Seongnam-si 13620 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Amsterdam 1066 CX Netherlands Details
Research Site Amsterdam 1081 HV Netherlands Details
Research Site Maastricht 6229 HX Netherlands Details
Research Site Nijmegen 6525 GA Netherlands Details
Research Site Rotterdam 3015GD Netherlands Details
Research Site Drammen 3004 Norway Details
Research Site Oslo N-0310 Norway Details
Research Site Trondheim 7030 Norway Details
Research Site A Coruña 15006 Spain Details
Research Site Barcelona 08025 Spain Details
Research Site Barcelona 08036 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Madrid 28046 Spain Details
Research Site Sevilla 41009 Spain Details
Research Site Stockholm 17176 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field